Director/PDMR Shareholding
RNS Number : 9316FLuceco PLC27 May 202627 May 2026
LUCECO PLC
Director PDMR / PCA Shareholdings
Luceco plc ("Luceco" or the "Company") announces that it has been informed of the following transactions by certain Directors and PCA's in ordinary shares of 0.05 pence each in the Company ("Ordinary Shares").
Giles Brand, Non-executive Chair, John Hornby (including via Deanmor Investments), Chief Executive Officer and ESO Investments 2 Limited, a PCA of the Chair, each sold Ordinary Shares for personal financial, estate planning and portfolio management purposes.
PDMR / PCA
Role
Ordinary Shares Sold
Sale price (p)
Ordinary Shares held post Transaction (#)
Ordinary Shares held post Transaction (% ISC)
Giles Brand
Non-executive Chair
475,000
268.52
8,991,919
5.59
John Hornby
Chief Executive Officer
1,000,000
268.52
12,028,054
7.48
Deanmor Investments1
PCA of CEO
100,000
275.50
13,000,000
8.08
ESO Investments 2 Limited
PCA of Chair
1,780,000
268.52
33,784,260
21.01
1 Deannmor Investments is a company owned by John Hornby and Philippa Hornby and their children.
For further information please contact:
Luceco plc
Contact
John Hornby, Chief Executive Officer
(Via Sodali & Co)
Will Hoy, Chief Financial Officer
Sodali & Co
Contact
James White
Pete Lambie
Tilly Abraham
078 5543 2699 / 079 3535 1934
The below notification made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:
1
Details of the Director / person discharging managerial responsibilities / person closely associated
a)
Name
Giles Brand
2
Reason for the notification
a)
Position/status
Non-executive Chair
b)
Initial notification / Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Luceco plc
b)
LEI
213800BBFZK4W4P98U76
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.0005 each
Identification code
GB00BZC0LP49
b)
Nature of the transaction
Sale of Ordinary Shares
c)
Price(s) and volume(s)
475,000 Ordinary Shares
268.52 pence per Ordinary Share
d)
Aggregated information
As above
- Aggregated volume
- Aggregated price
e)
Date of the transactions
26 May 2026
f)
Place of the transaction
London Stock Exchange
1
Details of the Director / person discharging managerial responsibilities / person closely associated
a)
Name
John Hornby
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification / Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Luceco plc
b)
LEI
213800BBFZK4W4P98U76
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.0005 each
Identification code
GB00BZC0LP49
b)
Nature of the transaction
Sale of Ordinary Shares
c)
Price(s) and volume(s)
1,000,000 Ordinary Shares
268.52 pence per Ordinary Share
d)
Aggregated information
As above
- Aggregated volume
- Aggregated price
e)
Date of the transactions
26 May 2026
f)
Place of the transaction
London Stock Exchange
1
Details of the Director / person discharging managerial responsibilities / person closely associated
a)
Name
Deanmor Investments
2
Reason for the notification
a)
Position/status
PCA of John Hornby
b)
Initial notification / Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Luceco plc
b)
LEI
213800BBFZK4W4P98U76
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.0005 each
Identification code
GB00BZC0LP49
b)
Nature of the transaction
Sale of Ordinary Shares
c)
Price(s) and volume(s)
100,000 Ordinary Shares
275.50 pence per Ordinary Share
d)
Aggregated information
As above
- Aggregated volume
- Aggregated price
e)
Date of the transactions
27 May 2026
f)
Place of the transaction
London Stock Exchange
1
Details of the Director / person discharging managerial responsibilities / person closely associated
a)
Name
ESO Investments 2
2
Reason for the notification
a)
Position/status
PCA of Giles Brand
b)
Initial notification / Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Luceco plc
b)
LEI
213800BBFZK4W4P98U76
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.0005 each
Identification code
GB00BZC0LP49
b)
Nature of the transaction
Sale of Ordinary Shares
c)
Price(s) and volume(s)
1,780,000 Ordinary Shares
268.52 pence per Ordinary Share
d)
Aggregated information
As above
- Aggregated volume
- Aggregated price
e)
Date of the transactions
26 May 2026
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHBXGDUCXDDGLR